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Abstract
Background and Aims: Free radicals are implicated in the aetiology of some gastrointestinal disorders such as gastric ulcer,
colorectal cancer and inflammatory bowel disease. In the present study we investigated the antioxidant and genoprotective
activity of some rotenoids (i.e. boeravinones) isolated from the roots of Boerhaavia diffusa, a plant used in the Ayurvedic
medicine for the treatment of diseases affecting the gastrointestinal tract.
Methods/Principal Findings: Antioxidant activity has been evaluated using both chemical (Electron Spin Resonance
spectroscopy, ESR) and Caco-2 cells-based (TBARS and ROS) assays. DNA damage was evaluated by Comet assay, while
pERK1/2 and phospho-NF-kB p65 levels were estimated by western blot. Boeravinones G, D and H significantly reduced the
signal intensity of ESR induced by hydroxyl radicals, suggesting a scavenging activity. Among rotenoids tested, boeravinone
G exerted the most potent effect. Boeravinone G inhibited both TBARS and ROS formation induced by Fenton’s reagent,
increased SOD activity and reduced H2O2-induced DNA damage. Finally, boeravinone G reduced the levels of pERK1 and
phospho-NF-kB p65 (but not of pERK2) increased by Fenton’s reagent.
Conclusions: It is concluded that boeravinone G exhibits an extraordinary potent antioxidant activity (significant effect in
the nanomolar range). The MAP kinase and NF-kB pathways seem to be involved in the antioxidant effect of boeravinone G.
Boeravinone G might be considered as lead compound for the development of drugs potentially useful against those
pathologies whose aetiology is related to ROS-mediated injuries.
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Introduction
Free radicals are (usually) highly reactive atomic or molecular
species with an unpaired number of electrons. Free radicals have
been implicated in the aetiology of various human diseases,
including gastrointestinal disorders (such as gastric ulcer,
colorectal cancer, inflammatory bowel disease, etc.) [1–5] and
play an important role as mediators of inflammation [6]. The
gastrointestinal tract is particularly well endowed with the
enzymatic machinery necessary to form large amounts of oxygen
radicals, e.g. mucosal xanthine oxidase and NADPH oxidase,
which occur in resident phagocytotic leukocytes of the lamina
propria. A number of studies have shown that certain indices of
oxidative stress (e.g. malondialdehyde, phospholipase A2 and
myeloperoxidase) are increased in intestinal tissues of patients
with disorders of the digestive system [7–10]. Other studies have
reported a relationship between glutathione depletion and gut
diseases [11–13]. Therefore, a new approach for the treatment of
gastrointestinal diseases could involve the use of antioxidants (to
prevent and neutralise toxic oxygen intermediates) or drugs
which increase the functionality of endogenous antioxidant
systems (such as superoxide dismutase, catalase or glutathione
peroxidase).
Boerhaavia diffusa is a herbaceous member of the Nyctagina-
ceae family which has a long history of use by indigenous and
tribal people of Brazil and India [14]. In particular, roots and
leaves of this plant have been widely used in the folk medicine
to treat several illnesses including those affecting the gastro-
intestinal tract (dyspepsia, abdominal pain, etc.). Experimental
studies have demonstrated that B. diffusa could be effective
in the prevention and treatment of diseases in which oxidants
or free radicals are implicated (i.e. inflammation, cancer,
diabetes, etc.) [15–19]. The main chemical ingredients of this
plant include alkaloids (punarnavine), rotenoids (boeravinones
A to J) and flavones [20]. In light of these data, in this paper we
evaluated the antioxidant/genoprotective effect of B. diffusa
and tried to identify the active ingredients responsible of its
activity.
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Preparation of the methanol extract and isolation of
rotenoids
Roots of Boerhaavia diffusa (2.20 lbs) were extracted with
methanol (363 L) at room temperature and the obtained extract
was subjected to Kupchan partitioning to obtain four different
fractions (n-hexane, CCl4, CHCl3, n-BuOH). Preliminary antiox-
idant assays showed that the CCl4 fraction possessed high
antioxidant activity, therefore, this fraction was further separated.
ESR-guided (see below) purification through sequential silica gel
column chromatography and HPLC as detailed in the Exper-
imental Section led to the isolation of boeravinone D (1, 6.4 mg),
boeravinone G (2, 7.5 mg) and boeravinone H (3, 5.2 mg) (Fig. 1).
The structures of these molecules were identified on the basis of
the comparison of their spectral data with those reported in the
literature [21,22].
Electron spin resonance spectroscopy
As shown in Figure 2, the reaction of Fe
2+ and H2O2 in the
presence of the spin trapping agent DMPO, generated a 1:2:2:1
quartet of lines in the ESR spectrum with the hyperfine coupling
parameters (aN and aH=14.9 G). BDME (0.1–5 mg/ml) produced
a concentration-dependent inhibition of the ESR signal intensity
of DMPO-OH spin adduct (antioxidant activity (AA) %: BDME
0.1 mg/ml 12.260.51, BDME 0.5 mg/ml 26.5560.62, BDME
1 mg/ml 52.3260.98, BDME 3 mg/ml 66.960.57, BDME
5 mg/ml 71.2260.43, n=3) (Fig. 2). Among the four fractions
(n-hexane, CCl4, CHCl3, n-BuOH) obtained from BDME through
a modified Kupchan partitioning procedure (see Materials and
Methods), the CCl4 and the n-BuOH ones were able to reduce the
ESR signal intensity, with the former more active (Table 1). The
carbon tetrachloride extract produced a total elimination of
hydroxyl radical (AA=100%) at the concentration of 0.7 mg/ml.
Chromatographic purification of the CCl4 fraction through
column chromatography on silica gel (see Materials and Methods)
led to the formation of 13 sub-fractions whose antioxidant activity
was evaluated through ESR assay (Table 2). HPLC purification of
the most active sub-fractions (BOE4, BOE6, BOE 8 and BOE 9)
led to the isolation of boeravinone G, boeravinone H and
boeravinone D (structures in Fig. 1) which, at the concentration
of 0.5 mg/ml, showed a scavenger activity of 65.963.3%,
50.262.4% and 48.661.4%, respectively.
Lipid peroxidation
The treatment with H2O2/Fe
2+ (1 mM) produced a significant
(p,0.001) threefold increase in TBARS formation (Fig. 3).
Boeravinone G (0.1–1 ng/ml) significantly and in a concentra-
tion-related manner (p,0.001) reduced H2O2/Fe
2+-induced
TBARS formation (Fig. 3). Boeravinone G given alone (i.e. in
absence of H2O2/Fe
2+ treatment), at all concentrations used, did
not modify the TBARS levels (pmol MDA/mg protein: control
168.5621.35, boeravinone G 0.1 ng/ml 175.8613.54, boeravi-
none G 0.3 ng/ml 173.3617.21, boeravinone G 1 ng/ml
171.8614.16; n=6).
Intracellular ROS
Exposure of Caco-2 cells to H2O2/Fe
2+ (2 mM) produced a
significant (p,0.001) increase in ROS formation (Fig. 4). A pre-
treatment for 24 h with boeravinone G (0.1–1 ng/ml) reduced the
ROS formation significantly (p,0.05-0.001) and in a concentra-
tion dependent manner as measured by the inhibition of DCF
fluorescence intensity (Fig. 4). Boeravinone G (0.1–1 ng/ml), given
alone (i.e. in absence of H2O2/Fe
2+ treatment), did not affect the
formation of ROS (Fluorescence intensity: control 2.4560.09,
boeravinone G 0.1 ng/ml 2.4560.14, boeravinone G 0.3 ng/ml
2.3660.17, boeravinone G 1 ng/ml 2.4260.09; n=6).
DNA damage
Boeravinone G (0.1–1 ng/ml) did not produce DNA damage
detected by the Comet assay in Caco-2 cells (% tail intensity:
control 5.3760.26, boeravinone G 0.1 ng/ml 5.2960.19, boer-
avinone G 0.3 ng/ml 5.2160.22, boeravinone G 1 ng/ml
5.3260.25; n=4), excluding a genotoxic effect. Exposure of the
Caco-2 cells to H2O2 (75 mM) produced a significant (p,0.001)
DNA damage (Fig. 5), expressed as comet tail intensity. Tail DNA
fluorescence of H2O2-damaged Caco-2 cells was about 43%, while
the control was about 5%. A pre-treatment with boeravinone G
(0.1–1 ng/ml) reduced significantly (p,0.001) and in a concen-
tration dependent manner the DNA damage induced by H2O2
(Fig. 5). Consistent with the TBARS assay, a significant in-
hibitory effect was achieved for the 0.1–1 ng/ml (boeravinone G)
concentrations.
SOD activity
Twenty-four hours exposure of Caco-2 cells to H2O2/Fe
2+
(1 mM) produced a significant (p,0.001) decrease in SOD activity
which was concentration-dependently counteracted by boeravi-
none G (Fig. 6). Interestingly, boeravinone G, at the highest
concentration tested (1 ng/ml), resulted in a SOD activity which
was significantly higher than the value measured in untreated cells
(i.e. cells not treated with H2O2/Fe
2+) (Fig. 6). Boeravinone G
(0.1–1 ng/ml), used alone (i.e. in absence of H2O2/Fe
2+
treatment), did not modify the activity of SOD [SOD activity
(ng/mg protein): control 17.760.64, boeravinone G 0.1 ng/ml
18.0260.90, boeravinone G 0.3 ng/ml 17.8660.96, boeravinone
G 1 ng/ml 17.260.79; n=6].
Figure 1. Chemical structure of the most potent antioxidant rotenoids. Rotenoids were obtained from Kupchan partitioning of the
methanol extract of B. diffusa root following by sequential silica gel column chromatography and HPLC.
doi:10.1371/journal.pone.0019628.g001
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Fenton’s reagent (H2O2/Fe
2+ 1 mM) elicited a significant
increase in the levels of phosphorylated ERK1 (pERK1), ERK2
(pERK2) and NF-kB p65 (Figure 7 and 8). Boeravinone G (at 0.3
and 1 ng/ml) significantly reduced the levels of pERK1 and
phospho-NF-kB p65 (Figure 7 and 8). However, at the lower
concentration of boheravinone G tested (i.e., 0.1 ng/ml), increased
levels of both pERK1 and phospho-NF-kB p65 were observed
(Figure 7 and 8). By contrast, boeravinone G, at all the
concentration evaluated (0.1–1 ng/ml), did not affect H2O2/
Fe
2+ -induced pERK2 up-regulation (Figure 7).
Cytotoxicity assays
The exposure of Caco-2 cells to various concentrations of the
most active antioxidant rotenoid boeravinone G (0.1–1 ng/ml)
resulted in no effect on cell survival (% cell survival: control
Table 1. Antioxidant activity (AA), detected using ESR assay, of the fractions obtained from Kupchan partitioning of the methanol
extract of B. diffusa root.
Extracts AA (%)
0.1 mg ml
21 0.5 mg ml
21 1m gm l
21 3m gm l
21 5m gm l
21
n-Hexane 0 0 0 0 0
Chloroform 0 0 0 0 0
Carbon tetrachloride 59.8760.65 85.4562.26 100601 0 0 601 0 0 60
n-Butanol 15.5060,39 35.5660.88 61.2261.66 68.9061.85 78.161.69
doi:10.1371/journal.pone.0019628.t001
Figure 2. Effect of 5 mg/ml of Boerhaavia diffusa methanol extract on electron spin resonance spectroscopy. Representative ESR spectra of
DMPO-OH spin adduct signal (A) and DMPO-OH spin adduct signal in the presence of 5 mg/ml of Boerhaavia diffusa methanol extract (B).
doi:10.1371/journal.pone.0019628.g002
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0.3 ng/ml 100.362.62, boeravinone G 1 ng/ml 99.763.69,
n=6).
Boeravinone G (0.1–1 ng/ml) did not produce any increase in
the release of LDH from Caco-2 cell line (% LDH leakage:
control 11.560.51, boeravinone G 0.1 ng/ml 9.860.39, boer-
avinone G 0.3 ng/ml 10.460.46, boeravinone G 1 ng/ml
10.860.55, n=6).
Discussion
Gastrointestinal diseases (such as gastric ulcer, colorectal cancer
and inflammatory bowel disease) are important public health
problems all over the world. There is a growing evidence that
oxygen-derived free radicals play an important role in the
pathogenesis of the digestive system disorders. Studies investigat-
ing the role of ROS in patients with IBD, have reported the
presence of abnormal high levels of these radicals [23,24].
Consistently, antioxidant compounds (e.g. polyphenols from green
tea) are believed to prevent a number of gastrointestinal diseases
[25–28] and drugs with antioxidant activity are currently used in
the treatment of these diseases [29–31].
In the present study, we have found that Boerhaavia diffusa,a n
Ayurvedic herbal medicine used for the treatment of several
gastrointestinal diseases, possesses remarkable antioxidant and
genoprotective properties which could contribute to explain, at
least in part, its traditional use in gastrointestinal ailments;
moreover, for the first time, we have demonstrated that rotenoids,
mainly boeravinone G, are responsible of this activity.
One of the approaches to assess the antioxidant activity is to
examine directly free radical production and inhibition by using
the highly sensitive electron spin resonance (ESR) spectroscopy,
which is able to detect the presence and concentration of oxygen
free radicals directly. Since hydroxyl radicals are very unstable, an
exogenous spin trap reacting with the free radical species was used,
thus generating more stable adducts with characteristic ESR
profiles. In the present study, it was found that a methanol extract
of B. diffusa (BDME) reduced the signal intensity of ESR, thus
suggesting a scavenging activity. Crude extracts obtained from
different parts of the plant (i.e. leaves) have already been shown to
exert antioxidant activity in liver and kidney of alloxan-induced
diabetic rats and in the liver damaged by acetaminophen [32,33].
In order to disclose the chemical components of BDME
responsible for the antioxidant activity, we have partitioned the
Figure 3. Effect of boeravinone G (0.1–1 ng/ml) on Fenton’s reagent (H2O2/Fe
2+ 1 mM)-induced malondialdehyde-equivalents
(MDA-equivalents) production. Effect observed in differentiated Caco-2 cells after 24-hour boeravinone G exposure. Data represent mean 6 SEM
of 6 experiments.
#p,0.001 vs control (vehicle) and ***p,0.001 vs H2O2/Fe
2+ alone.
doi:10.1371/journal.pone.0019628.g003
Table 2. Antioxidant activity (AA), detected using ESR assay,
of the fractions obtained from the carbon tetrachloride
extract of B. diffusa root.
CCl4 fractions AA (%)
0.01 mg ml
21 0.15 mg ml
21 1m gm l
21
BOE 1 26.3260.44 76.8761.28 91.5061.52
BOE 2 24.4160.41 78.0561.30 92.2061.55
BOE 3 23.2260.39 77.4561.29 88.4561.47
BOE 4 31.2460.52 82.9361.39 98.7560.48
BOE 5 20.1360.33 65.8561.09 82.3161.37
BOE 6 30.1260.50 81.7161.36 10060
BOE 7 24.1360.0.40 75.6161.26 86.7161.44
BOE 8 33.3460.55 82.3261.37 10060
BOE 9 32.9860.54 81.7161.36 10060
BOE 10 0 12.1960.20 51.2560.85
BOE 11 22.3260.37 75.6161.26 90.8161.51
BOE 12 15.1260.25 51.2260.85 75.2561.25
BOE 13 20.1260.33 75.6161.26 88.4561.48
doi:10.1371/journal.pone.0019628.t002
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n-hexane, CCl4, CHCl3, n-BuOH). An ESR-guided fractionation
of the most potent antioxidant fraction (CCl4) led to the isolation
of three rotenoids, boeravinone D [21], G [22] and H [22] with a
remarkable radical-scavenging activity. The chemical structures of
these compounds are reported in Figure 1. Since our previous
investigations revealed that the rotenoid mixture of B. diffusa roots
is actually made up by at least fifteen compounds [34,35], we were
surprised to notice that only boeravinones D, G, and H seemed to
play a major role in the antioxidant activity of the extract.
Common features of compounds 1–3 are a planar ring C, the
presence of free hydroxyl groups on ring A and at position 11, and
the presence of a methoxy group at position 6. Remarkably, in the
pool of rotenoids present in B. diffusa roots [34,35], boeravinones
D, G, and H are the only ones to possess, at the same time, all
these features. Moreover, the higher activity of boeravinone G
compared to H and D could be ascribed to the absence of the
methyl group at position 10 (see figure 1). Since boeravinone G
exhibited a higher activity compared to boeravinones D and H,
further experiments were performed on this plant compound.
Using the Caco-2 cell line (a human cell line which mimics, after
differentiation, the intestinal epithelium) and H2O2 as a free
radical generator, we further investigated the antioxidant effect of
boeravinone G by evaluating the lipid peroxidation, assessed as
MDA-equivalents, and the production of ROS.
Lipid peroxidation is a complex process that occurs in biological
membranes that contain oxidation-susceptible polyunsaturated
fatty acids, and leads to the production of lipid hydroperoxides and
their metabolites. The cytosolic levels of malondialdehyde and its
reactive equivalents are adequate indicators of lipid peroxidation.
In the present study, we not only report for the first time the
antioxidant activity of boeravinone G in the intestinal cells using
the TBARS assay, but also confirm the antioxidant activity using a
more specific assay. Specifically, through a fluorescent approach,
we have demonstrated that boeravinone G reduced the ROS
formation generated by Fenton’s reagent. Indeed, although
Figure 5. Effect of boeravinone G (BG, 0.1–1 ng/ml) on DNA
damage. DNA damage (tail intensity) was detected by the Comet assay
in Caco-2 cells exposed to 75 mMH 2O2 for 5 min in absence or presence
of boeravinone G. a=control; b=H2O2 75 mM; c=H2O2 75 mM+BG
0.1 ng/ml; d=H2O2 75 mM+BG 0.3 ng/ml; e=H2O2 75 mM+BG 1 ng/ml.
Data represent mean 6 SEM of 4 experiments.
#p,0.001 vs control
(vehicle) and ***p,0.001 vs H2O2 alone.
doi:10.1371/journal.pone.0019628.g005
Figure 6. Effect of boeravinone G (0.1–1 ng/ml) on superoxide
dismutase (SOD) activity. SOD activity was evaluated in Caco-2 cells
exposed to Fenton’s reagent (H2O2/Fe
2+ 1 mM) without or with
boeravinone G (0.1–1 ng/ml). Data represent mean 6 SEM of 4
experiments.
#p,0.001 vs control (vehicle); *p,0.05 and ***p,0.001 vs
H2O2/Fe
2+ alone; up,0.05 vs control.
doi:10.1371/journal.pone.0019628.g006
Figure 4. Effect of boeravinone G (0.1–1 ng/ml) on Fenton’s
reagent (H2O2/Fe
2+ 2 mM)-induced reactive species (ROS)
production. Effect observed in differentiated Caco-2 cells after 24-
hour boeravinone G exposure. Data represent mean 6 SEM of 6
experiments.
#p,0.001 vs control (vehicle); *p,0.05, **p,0.01 and
***p,0.001 vs H2O2/Fe
2+ alone.
doi:10.1371/journal.pone.0019628.g004
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biological species can react with thiobarbituric acid [35].
Importantly, the antioxidant activity of boeravinone G occurs at
nanomolar concentrations, while other well known antioxidant
compounds, such as vitamins C and E exert antioxidant activity in
the micromolar range [36,37].
A great number of in vitro experiments showed that ROS
damages DNA, which appears to represent the major target
involved in mutagenesis, carcinogenesis and aging cell responses
[38,39]. Therefore, we also evaluated the potential genoprotective
effect of boeravinone G on ROS-induced DNA damage. DNA
damage, induced by using H2O2 (a well-known genotoxic agent
able to induce oxidative DNA damage) was evaluated by the
Comet assay, which is a very sensitive method for the evaluation of
genotoxic/genoprotective effects [40]. Even if we used different
concentrations of H2O2 in the various assays, our experiments
suggest that the protective action of boeravinone G, assessed by
the TBARS and the ROS assays (see above), could be related to
reduction of DNA damage induced by H2O2. Indeed, boeravi-
none G was able to reduce H2O2-induced DNA damage
significantly at the concentration of 0.1–1 ng/ml.
In order to investigate the potential targets involved in the
boeravinone G antioxidant/genoprotective action, we have
analyzed the effect of this plant ingredient on an antioxidant
defence enzyme (SOD) and on two signal transduction pathways
(MAP kinase and NF-kB) that play a pivotal role in the oxidative
stress-induced gastrointestinal disorders [41,42].
SOD is one of the most effective intracellular enzymatic
antioxidants and it acts catalyzing the dismutation of superoxide
into oxygen and hydrogen peroxide. According to previous work
[43,44], we have shown a significant decrease in SOD activity in
intestinal epithelial cells treated with H2O2/Fe
2+. Boeravinone G
counteracted the decreased SOD activity thus suggesting a
stimulatory effect of this compound on the defence mechanisms
of the cells.
When generation of ROS exceeds the capability of the cellular
defence systems, several signalling protein kinases and transcrip-
tion regulatory factors are activated [41,42,45]. Indeed, oxidative
stress leads to activation of extracellular-signal-related kinases
(ERKs) [46–48], which are members of the mitogen-activated
protein kinase (MAPK) family, and nuclear factor kB (NF-kB) [49].
NF-kB and MAPK are distinct signalling transduction pathways,
although, recently, in several situations including oxidative stress,
it has been demonstrated a considerable cross talk between these
two pathways [50,51]. We have observed that exposure of Caco-2
to Fenton’s reagent leads to an activation of ERK1 and ERK2.
More importantly, we have shown that boeravinone G, at the
concentrations of 0.3 and 1 ng/ml, counteracted the increased
ERK phosphorylation induced by H2O2/Fe
2+-exposure. Surpris-
ingly, the effect of boeravinone G on the ERK phosphorilation
was significant only for the 44-kDa isoform pERK1 (and not for
the pERK2 isoform) suggesting a selectivity of action. A differential
role for the two kinases in cell signalling has been previously
documented [52]. The down-regulation in ERK phosphorylation
after boeravinone G exposure is consistent with the observed effect
of this compound on SOD activity. Indeed, it is well known the
strict correlation existing between Cu-Zn SOD enhancement and
ERKs phosphorilation inhibition [53]. Further studies are needed
Figure 7. Effect of boeravinone G (0.1–1 ng/ml) on pERK1 (A) and pERK2 (B) expression. Quantitative analysis and representative western
blot analysis of pERK1 and pERK2 in Caco-2 cells exposed to Fenton’s reagent (H2O2/Fe
2+ 1 mM) without or with boeravinone G (0.1–1 ng/ml). The
results were normalized with anti-ERK2 (pERK1/2/ERK2).
#p,0.01 vs control (vehicle); ***p,0.001 vs H2O2/Fe
2+ alone.
doi:10.1371/journal.pone.0019628.g007
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mediated ERK and NF-kB activation or, alternatively, if
boeravinone G affects the activation of ERK and NF-kB induced
by other stimuli (for example, EGFR/RTK-mediated activation).
Similarly, we have here found an increase in phosphorylated
NF-kB p65 levels in differentiated Caco-2 cells during the
oxidative stress and such increase was counteracted by boeravi-
none G. The inhibitory effect of boeravinone G on Fenton’s
reagent-induced phosphorylated p65 up-regulation suggests an
involvement of this pathway in the boeravinone G antioxidant
activity.
Since boeravinones belong to the chemical class of rotenoids,
widely used as botanical insecticides and generally characterized
by high toxicity [54], we carried out additional experiments to
ensure that boeravinone G, at the concentrations used in our
experiments, did not exert any toxic effects. Cytotoxicity was
assessed quantitatively by both MTT and LDH assays. We
observed no decrease in the cell viability and no increase of LDH
release when Caco-2 cells were incubated in the presence of
boeravinone G. Moreover, the lack of boeravinone G toxicity has
also been demonstrated by the Comet assay since the rotenoid,
administered alone (i.e. in absence of damage induced by H2O2)
did not affect DNA integrity. Collectively, these results suggest that
boeravinone G was neither cytotoxic nor genotoxic in Caco-2
cells. Accordingly, an interesting study aimed at establishing the
‘‘toxophore’’ of rotenoid molecules, revealed that a prenyl-derived
ring attached at ring D and a dimethoxy substitution on ring A are
essential requirements [55]. Luckily, both these features are
missing in B. diffusa rotenoids.
In conclusion, the results obtained in this study demonstrate
that BDME exerts antioxidant activity; boeravinone G, H and D
appear to be the major compounds responsible for the antioxidant
activity, with boeravinone G playing a major role. The
genoprotective effect of boeravinone G was associated to a
reduction of Fenton’s reagent-induced up-regulation of pERK1
and NF-kB levels.
In the light of the importance of antioxidant/genoprotective
activity in the treatment or prevention of gut disorders and since
our experiments were performed on isolated intestinal cells, it is
suggested that the antioxidant activity here reported could explain,
at least in part, the traditional use of this Ayurvedic remedy in
treatment of gastrointestinal disorders (including inflammatory
bowel disease and colorectal cancer). Obviously, in vivo studies,
using well-established animal models of inflammatory bowel
disease and colon cancer, are needed to further confirm our
hypothesis. The relatively simple chemical structure of boeravi-
nones and the preliminary structure-antioxidant activity relation-
ships presented here should be helpful in this task.
Materials and Methods
Chemicals
5,5-dimethyl-1-pyrroline-N-oxide (DMPO), hydrogen peroxide
(H2O2), FeCl2?4H2O, trichloroacetic acid (TCA), thiobarbituric
Figure 8. Effect of boeravinone G (0.1–1 ng/ml) on phospho-NF-kB p65 expression. Quantitative analysis and representative western blot
analysis of phospho-NF-kB p65 in Caco-2 cells exposed to Fenton’s reagent (H2O2/Fe
2+ 1 mM) without or with boeravinone G (0.1–1 ng/ml). The
results were normalized with anti-bactin antibodies.
#p,0.001 vs control (vehicle); *p,0.05 and ***p,0.001 vs H2O2/Fe
2+ alone.
doi:10.1371/journal.pone.0019628.g008
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2,5-diphenyltetrazolium bromide (MTT), 2–7-dichlorofluorescein
diacetate (DCFH-DA) and Phosphate buffered saline (PBS) tablets
were purchased from Sigma-Aldrich (Milan, Italy). Monoclonal
primary antibodies for pERK1/2, ERK2 and phospho-NF-kB p65
were obtained from Santa Cruz Laboratories (DBA S.r.l, Italy)
while peroxidase-conjugated (HRP) anti-mouse IgG antibody was
obtained from JacksonImmunoResearch (LiStarFish, Italy). All
reagents for cell culture and western blot analysis were obtained
from Sigma Aldrich S.r.l. (Milan, Italy), Amersham Biosciences
Inc. (UK), Bio-Rad Laboratories (USA) and Microglass Heim
S.r.l. (Naples, Italy). All chemicals and reagents employed in this
study were of analytical grade.
Plant material, extraction and isolation
Roots of Boerhaavia diffusa L. (Nyctaginaceae), collected in
Bangalore (India), were kindly provided by Dr. Carlo Sessa,
Milan. Fresh whole plants (2.20 lbs) including rootstocks and roots
were extracted (363 L) with methanol at room temperature.
Evaporation of the pooled extracts left a brown material (16.4 g)
that was then subjected to a modified Kupchan’s partition scheme
[56] as follows. This crude methanol extract (BDME) was
dissolved in MeOH-H2O 9:1 and then partitioned against n-
hexane (36500 ml) to yield an apolar fraction weighing 1.55 g.
Subsequently, the water content of the hydromethanolic phase was
adjusted to 20% (v/v) and 40% (v/v) and the solutions partitioned
against carbon tetrachloride (CCl4,3 6500 ml) and chloroform
(CHCl3,3 6500 ml), respectively, affording CCl4 (g 0.56) and
CHCl3 (g 0.90) fractions. Finally, all the MeOH was evaporated
from the hydromethanolic layer, and the water solution thus
obtained was partitioned against n-BuOH to yield butanol (1.32 g)
and water (7.0 g) fractions. The CCl4 fraction was chromato-
graphed by MPLC on silica gel (230–400 mesh) column
(750625 mm), using a linear gradient system (400 ml for each
solvent) from n-hexane to EtOAc to MeOH-EtOAc (1:1). The
obtained fractions were pooled on the basis of their TLC behavior
to afford 13 fractions called BOE-1 to BOE-13. Fractions BOE-4,
BOE-6, BOE-8, and BOE-9, were further separated by HPLC.
Both fractions BOE-4 (n-hexane-EtOAc, 8:2) and BOE-6 (n-
hexane-EtOAc, 7:3) were purified by HPLC on an analytical
column (25064.6 mm) using n-hexane-EtOAc 75:25 as eluent
(flow rate 1.0 ml/min) and afforded as the main component
boeravinone D (1, Figure 1, 6.4 mg). The BOE-8 fraction (eluted
with hexane/EtOAc 6:4) was purified by HPLC on an analytical
column using hexane/EtOAc 7:3 as eluent, flow rate 1.0 ml/min,
obtaining boeravinone G (2, Figure 1, 7.5 mg). Finally, the BOE-9
fraction (eluted with hexane/EtOAc 1:1) was purified by HPLC
on an analytical column using hexane/EtOAc 6:4 as eluent, flow
rate 1.0 ml/min, obtaining boeravinone H (3, Figure 1, 5.2 mg).
The chemical structures of these molecules were identified on
the basis of the comparison of their spectral data with those
reported in the literature [21,22]. Boeravinone G was dissolved in
dimethylsulphoxide (DMSO) to obtain a final concentration of
0.1% (w/w) in the culture medium; this drug vehicle had no effect
on the responses under study.
Cell culture
Human colon adenocarcinoma Caco-2 cells were purchased
from the American Type Culture Collection (LGC Promochen,
Italy) and used between passages 30 to 50. The cells were routinely
maintained in 75 cm
2 polystyrene flasks in growth media
consisting of DMEM (Dulbecco’s Modified Eagle Medium)
containing 10% Fetal Bovine Serum (FBS), 100 U/ml penicillin,
100 mg/ml streptomycin, 1 M Hepes [4-(2-Hydroxyethyl)-
1-piperazineethanesulfonic acid] 2.5%, non-essential amino acid
(NEAA) 16, 2 mM L-glutamine at 37uC in a 5% CO2
atmosphere. The medium was changed every 48 h. For cell
vitality, lactate dehydrogenase leakage, TBARS and ROS assays
cells were led to differentiation, (cells were used at post-confluence
stage as a model of human enterocytes); preliminary experiments
showed that a 7-day time of incubation was required for Caco-2
cells to undergo differentiation.
Hydroxyl radical generation and detection (electron spin
resonance spectroscopy)
Hydroxyl free radicals were obtained by the Fenton reaction:
0.2 ml H2O2 (10 mM) and 0.2 ml FeCl2?4H2O (10 mM) mixed
with 0.2 ml 5,5-dimethyl-1-pyrroline-N-oxide (DMPO, 0.3 M)
used as spintrap (blank). Hydroxyl radicals production was detected
by the ESR spectrometer Bruker 3000E (Rheinstetten, Germany)
with the following settings: field modulation 100 kHz, modulation
amplitude 0.512 G, receiver gain 2610
5, time constant 81.92 ms,
conversion time 163.84 ms, center field 3440.00 G, sweep width
100.00 G, x-band frequency 9.64 GHz, power 20 mW, tempera-
ture 23uC [57]. The influence of BDME and its fractions/
constituents on the formation and transformation of hydroxyl
radicals was investigated by adding the extract to the Fenton
reaction system in the range of concentrations 0.10–5 mg/ml and
0.01–1 ml for BDME and fractions, respectively. The ESR spectra
were recorded after 5 min. The antioxidant activity (AA) value of
the extract was defined as: AA=1006(h02hx)/ho (%) where ho and
hx are the height of the first peak in the ESR spectrum of DMPO-
OH spin adduct of the blank and the probe, respectively.
TBARS assay
Lipid peroxidation products [thiobarbituric acid reactive
substances (TBARS) also known as malondialdehyde-equivalents
(MDA-equivalents)] from Caco-2 cells were measured by the
thiobarbituric acid colorimetric assay. Briefly, Caco-2 cells were
seeded in 6-well plates at the density of 3.0610
6 and led to
differentiation. Differentiated cells were treated with boeravinone
G (0.1–1 ng/ml corresponding to 0.28–2.8 nM) for 24 h and then
washed with PBS and incubated with the Fenton’s reagent (H2O2/
Fe
2+ 1 mM) for 3 h at 37uC. The 1 mM concentration was
selected on the basis of our preliminary experiments, which
showed submaximal effects of H2O2/Fe
2+ in this assay (pmol
MDA/mg protein: control 182.1617.90, H2O2/Fe
2+ 0.25 mM
182.6620.68, H2O2/Fe
2+ 0.5 mM 298.5617.62, H2O2/Fe
2+
1 mM 628.5634.58, H2O2/Fe
2+ 2 mM 985.5662.5, H2O2/
Fe
2+ 4 mM 1039662.3; n=8. EC50: 0.9660.07 mM, Emax:
1052650.37%). After incubation, the cells were washed and
scraped in ice cold PBS. The cells were lysed by six cycles of
freezing and thawing in PBS and then centrifuged at 162006g for
10 min at 4uC. Trichloroacetic acid (TCA, 10% w/v) was added
to the cellular lysate and, after centrifugation at 162006 g for
10 min, 0.67% (w/v) thiobarbituric acid (TBA) was added to the
supernatant and the mixture was heated at 80uC for 30 min. After
cooling, MDA-equivalents formation was recorded at the
wavelength of 532 nm, using a Beckman DU62 spectrophotom-
eter. A standard curve of MDA was used to quantify the levels of
MDA-equivalents formed during the experiments, and the results
are presented as mmol of MDA-equivalents/mg of cell protein
previously determined by the Bradford method [58].
Detection of reactive oxygen species (ROS) generation
Generation of intracellular reactive oxygen species (ROS) was
estimated by a fluorescent probe, DCFH-DA [59]. DCFH-DA
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hydrolyzed by intracellular esterases to form non-fluorescent
DCFH, which is then rapidly oxidized to form highly fluorescent
DCF in the presence of ROS. The DCF fluorescence intensity is
paralleled to the amount of ROS formed intracellularly. For
experiments, cells were plated in a 96 multiwell plate at the density
of 1610
4 cells/well and led to differentiation. Confluent Caco-2
cell monolayers were incubated for 24 h at 37uC with boerhavi-
none G (0.1–1 ng/ml). Then, the cells were rinsed and incubated
for 30 min with 100 mM DCFH-DA in Hanks’ Balanced Salt
Solution (HBSS) containing 1% FBS. Finally, cells were rinsed and
incubated with the Fenton’s reagent (H2O2/Fe
2+ 2 mM) for 3 h at
37uC. The 2 mM concentration of H2O2/Fe
2+ induced a
submaximal increase in ROS production (control 2.2660.19,
H2O2/Fe
2+ 0.5 mM 2.6160.19, H2O2/Fe
2+ 1 mM 10.2961.27,
H2O2/Fe
2+ 2 mM 27.3461.29, H2O2/Fe
2+ 3 mM 39.4363.13,
H2O2/Fe
2+ 4 mM 44.2362.31; n=8. EC50: 2.2960.07 mM,
Emax: 54.4069.11%). The DCF fluorescence intensity was
detected using a fluorescent microplate reader (Perkin-Elmer
Instruments), with the excitation wavelength of 485 nm and the
emission wavelength of 538 nm.
DNA damage assay
The presence of DNA fragmentation was examined by single
cell gel electrophoresis (Comet assay), as previously described [60].
Briefly, Caco-2 cells were seeded in the 25 cm
2 flasks at a density
of 4610
5 cells and incubated with boeravinone G (0.1–1 ng/ml) at
37uC for 24 h. After incubation the cells were treated with H2O2
(75 mM) for 5 min on ice and then centrifuged at 10006 g for
5 min. This concentration of H2O2 produced a submaximal
damage of DNA (data not shown). The supernatant was discarded
and the pellet was mixed with 85 ml of 0.85% low melting point
agarose (LMA) in PBS. Cells were added to previously prepared
gels of 1% normal agarose (NMA). The gels on frosted slides were
maintained in lysis solution (2.5 M NaCl, 100 mM Na2EDTA,
10 mM Tris and 1% Triton X-100, pH 10) at 4uC for 1 h, and
then electrophoresed in an appropriate buffer (300 mM NaOH,
1m MN a 2EDTA, pH.12) at 26 V, 300 mA for 20 min. After
running, the gels were neutralized in 0.4 M Tris–HCl, pH 7.5
(365 min washes) and stained with 20 ml of ethidium bromide
(2 mg/ml) before scoring. Images were analyzed using a fluores-
cence microscope (Nikon) interfaced with a computer. DNA
damage was analyzed and quantified by measuring the percent of
fluorescence intensity in the tail (tail intensity) through the Komet
5.0 image analysis software (Kinetic Imaging). Each treatment was
carried out in duplicate, and 100 random selected comets from
two microscope slides were analyzed.
Preparation of cytosolic fractions
Caco-2 cytosolic extracts were prepared as previously described
[60]. Briefly, after boeravinone G (0.1–1 ng/ml) incubation for
24 hours followed by a treatment with H2O2/Fe
2+ 1 mM for
3 hours, the medium was removed and cells were washed with ice
cold PBS. The cells were collected by scraping for 10 min at 4uC
with lysis buffer [50 mM Tris-HCl pH=7.4, 0.25% sodium
deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM NaF, 1% NP-
40, 1 mM PMSF, 1 mM Na3VO4 containing complete protease
inhibitor cocktail (Roche Diagnostics, Mannheim, Germany)].
After centrifugation at 16,2006 g for 15 min at 4uC, the
supernatants were collected and protein concentration was
determined by Bradford method [58]. Cytosolic lysates were used
for the evaluation of SOD activity, and pERK1/2 and phospho-
NF-kB p65 levels.
Superoxide dismutase (SOD) assay
A modified version of the Kuthan and colleagues method was
used to detect SOD activity [61]. In this method, superoxide
radicals were generated using a xanthine oxidase/hypoxanthine
system, and the ability of cells to scavenge superoxide radicals was
measured spectrophotometrically. Cytosolic lysates were incubated
at 25uC for 20 min with a reaction mixture containing 1.2 mM
xanthine, 0.03 mM nitro blue tetrazolium (NBT), 0.26 U/mL
xanthine oxidase. Absorbance readings at 560 nm were recorded
using a Beckman DU62 spectrophotometer. Superoxide radical-
scavenging capacity of boeravinone G (0.1–1 ng/ml) at the end of
30 min were expressed as ng SOD/mg proteins contained in the
cell lysates.
Western blot analysis
Proteins (50 mg) were subjected to electrophoresis on an SDS
12% polyacrylamide gel and electrophoretically transferred onto a
nitrocellulose transfer membrane (Protran, Schleicher & Schuell,
Germany). The immunoblots were developed with 1:1000 dilution
for pERK1, pERK2 and phospho-NF-kB p65, and the signals were
detected with the ECL System according to the manufacturer’s
instructions (Amersham Pharmacia Biotech). The membranes
were probed with an anti-ERK2 and anti-bactin antibody, to
normalize the results, which were expressed as a ratio of
densitometric analysis of pERK1/2/ERK2 and phospho-NF-kB
p65/b-actin bands, respectively.
Cell viability
Cellular viability was assessed by the MTT [3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide] assay as described by
Mosmann [62]. Caco-2 cells were plated in a 96 multiwell plate at
a density of 1610
4 cells/well. After differentiation the cells were
treated with vehicle (DMSO 0.1% v/v) or boeravinone G (0.1–
1 ng/ml) for 24 h and, then, incubated with the MTT solution
(0.25 mg/ml) for 1 h at 37uC. The supernatant was removed and
the formed formazan crystals were dissolved in DMSO (100 ml/
well) at room temperature for 10 min. The absorbance was read at
the wavelength of 490 nm in a multiwell plate reader (Bio-Rad,
Model 550). The mean absorbance, taken from cells grown in the
absence of the extracts (vehicle alone), was taken as 100% cell
survival (control).
Lactate dehydrogenase (LDH) leakage assay
The injury to Caco-2 cells was quantitatively assessed through
the measurement of lactate dehydrogenase (LDH) levels. Caco-2
cells were seeded in 6-well plates at the density of 3.0610
6 and
led to differentiation. Differentiated cells were treated with
vehicle (DMSO 0.1% v/v) or boeravinone G (0.1–1 ng/ml) for
24 h. An aliquot of the medium was removed from the culture
plates and then analyzed for LDH leakage into the culture media
by using a commercial kit (Sigma Diagnostics). The total LDH
activity was determined after cells were scraped and thoroughly
disrupted by Ultra Turax for 30 seconds. The percentage of
LDH leakage was calculated to determine membrane integrity.
The LDH leakage was expressed as a percentage of the total
activity: (activity in the medium)/(activity in the medium+activity
of the cells)6100.
Statistical analysis
Statistical analysis was carried out using GraphPad Prism 4.01
(GraphPad Software, San Diego, CA, USA). All data were
expressed as mean 6 SEM of duplicate determinations and are
representative of at least three determinations. Groups of data
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by Tukey’s multiple comparison tests. Values of P,0.05 were
regarded as significant. The IC50 and Emax values were calculated
by nonlinear regression analysis using the equation for a sigmoid
concentration– response curve (GraphPad Prism).
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